WallStSmart

Plexus Corp (PLXS)vsSynopsys Inc (SNPS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Synopsys Inc generates 94% more annual revenue ($8.01B vs $4.13B). SNPS leads profitability with a 13.8% profit margin vs 4.3%. PLXS appears more attractively valued with a PEG of 2.09. PLXS earns a higher WallStSmart Score of 51/100 (C-).

PLXS

Buy

51

out of 100

Grade: C-

Growth: 5.3Profit: 5.5Value: 6.0Quality: 8.5
Piotroski: 6/9Altman Z: 3.24

SNPS

Hold

47

out of 100

Grade: D+

Growth: 6.7Profit: 5.0Value: 3.0Quality: 4.5
Piotroski: 1/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PLXSUndervalued (+71.3%)

Margin of Safety

+71.3%

Fair Value

$713.29

Current Price

$250.58

$462.71 discount

UndervaluedFair: $713.29Overvalued

Intrinsic value data unavailable for SNPS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PLXS2 strengths · Avg: 9.5/10
Altman Z-ScoreHealth
3.2410/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.159/10

Conservative balance sheet, low leverage

SNPS2 strengths · Avg: 9.5/10
Revenue GrowthGrowth
65.5%10/10

Revenue surging 65.5% year-over-year

Market CapQuality
$92.45B9/10

Large-cap with strong market position

Areas to Watch

PLXS4 concerns · Avg: 3.3/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

P/E RatioValuation
39.0x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

Free Cash FlowQuality
$-50.58M2/10

Negative free cash flow — burning cash

SNPS4 concerns · Avg: 2.5/10
Return on EquityProfitability
5.5%3/10

ROE of 5.5% — below average capital efficiency

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
3.172/10

Expensive relative to growth rate

P/E RatioValuation
74.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : PLXS

The strongest argument for PLXS centers on Altman Z-Score, Debt/Equity.

Bull Case : SNPS

The strongest argument for SNPS centers on Revenue Growth, Market Cap. Revenue growth of 65.5% demonstrates continued momentum.

Bear Case : PLXS

The primary concerns for PLXS are PEG Ratio, P/E Ratio, Profit Margin. Thin 4.3% margins leave little buffer for downturns.

Bear Case : SNPS

The primary concerns for SNPS are Return on Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.3x leaves little room for execution misses.

Key Dynamics to Monitor

PLXS profiles as a value stock while SNPS is a growth play — different risk/reward profiles.

SNPS carries more volatility with a beta of 1.15 — expect wider price swings.

SNPS is growing revenue faster at 65.5% — sustainability is the question.

SNPS generates stronger free cash flow (822M), providing more financial flexibility.

Bottom Line

PLXS scores higher overall (51/100 vs 47/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Plexus Corp

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Plexus Corp. The company is headquartered in Neenah, Wisconsin.

Visit Website →

Synopsys Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Synopsys is an American electronic design automation company that focuses on silicon design and verification, silicon intellectual property and software security and quality. Products include logic synthesis, behavioral synthesis, place and route, static timing analysis, formal verification, hardware description language (SystemC, SystemVerilog/Verilog, VHDL) simulators, and transistor-level circuit simulation.

Visit Website →

Want to dig deeper into these stocks?